diatrizoate meglumine has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marmor, JB; Oppenheimer, DA; Young, SW | 1 |
| Avrahami, E; Cohn, DF; Weiss-Peretz, J | 1 |
2 other study(ies) available for diatrizoate meglumine and Malignant Melanoma
| Article | Year |
|---|---|
Work in progress: serial evaluation of tumor volume using computed tomography and contrast kinetics.
Topics: Carcinoma, Squamous Cell; Diatrizoate; Diatrizoate Meglumine; Evaluation Studies as Topic; Humans; Kinetics; Melanoma; Time Factors; Tomography, X-Ray Computed | 1983 |
Focal epileptic activity following intravenous contrast material injection in patients with metastatic brain disease.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Contrast Media; Diatrizoate Meglumine; Dysgerminoma; Epilepsies, Partial; Female; Humans; Infusions, Intravenous; Ioxaglic Acid; Lung Neoplasms; Male; Melanoma; Middle Aged; Skin Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed | 1987 |